As of 2026-10-12, the Intrinsic Value of Antibe Therapeutics Inc (ATE.TO) is -1.77 CAD. This ATE.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.30 CAD, the upside of Antibe Therapeutics Inc is -701.01%.
Based on its market price of 0.30 CAD and our intrinsic valuation, Antibe Therapeutics Inc (ATE.TO) is overvalued by 701.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.77 - -1.77 | -1.77 | -701.01% |
| P/E | (2.33) - (5.21) | (3.73) | -1365.1% |
| DDM - Stable | (3.32) - (28.88) | (16.10) | -5558.6% |
| DDM - Multi | (0.11) - (0.73) | (0.19) | -164.0% |
| Market Cap (mil) | 15.53 |
| Beta | -0.16 |
| Outstanding shares (mil) | 52.65 |
| Enterprise Value (mil) | 11.43 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.29% |
| Cost of Debt | 5.00% |
| WACC | 5.99% |